Ignite Creation Date:
2024-05-06 @ 6:53 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05823779
Status:
RECRUITING
Last Update Posted:
2023-04-21
First Post:
2023-04-09
Brief Title:
A 48 Week Observational Study of the Frequency of Symptomatic Herpes Virus I and II in HIV Infected Subjects
Sponsor:
Global Research Institute
Organization:
Global Research Institute
Study Overview
Official Title:
A 48 Week Observational Study of the Frequency of Symptomatic Herpes Virus I and II in HIV Infected Subjects
Status:
RECRUITING
Status Verified Date:
2023-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HSVHIV
Brief Summary:
This study is an observational cohort prospective study looking at the frequency of Herpes Simplex Virus HSV 1 and or 2 outbreaks in HIV positive patients whos HIV virus is controlled on highly active anti-retroviral therapy We will be enrolling fifty 50 patients
Detailed Description:
We will be confirming that the patients are HIV positive and has antibodies to either HSV 1 or HSV 2 as part of the screening process If so we will then obtain patient baseline HIV-PCR CD4 medial history including medications on day one Whether the patient is on any or no herpes controlling medication If the patient has what they feel is a flare up of HSV they will come into clinic where the lesion will be culture and the patients HIV-PCR and CD4 will also be obtained Otherwise the patient will receive phone follow ups every three months to see if there has been and change in their health or medications The main endpoint is to see if there is a correlation between outbreaks in HIV patients and their CD4 cells andor HIV andor Herpes medication
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None